Your browser doesn't support javascript.
loading
Late-Onset Molybdenum Cofactor Deficiency Type A: A Treatable Cause of Developmental Delay.
Lund, Allan M; Berland, Siren; Tangeraas, Trine; Christensen, Mette; Confer, Nils; Squires, Liza; Brannsether, Bente.
Affiliation
  • Lund AM; Department of Clinical Medicine, University of Copenhagen, and Centre for Inherited Metabolic Diseases, Departments of Pediatrics.
  • Berland S; Clinical Genetics, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
  • Tangeraas T; European Reference Network for Hereditary Metabolic Disorders.
  • Christensen M; Department of Medical Genetics, Haukeland University Hospital, Bergen, Norway.
  • Confer N; European Reference Network for Hereditary Metabolic Disorders.
  • Squires L; Norwegian National Unit for Newborn Screening, Division of Paediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway.
  • Brannsether B; Department of Medical Genetics, Haukeland University Hospital, Bergen, Norway.
Pediatrics ; 153(6)2024 Jun 01.
Article in En | MEDLINE | ID: mdl-38808412
ABSTRACT
Molybdenum cofactor deficiency classically presents in neonates with intractable seizures; however, milder cases generally present before age 2 years with developmental delays and may go undiagnosed. Early diagnosis, and safe, US Food and Drug Administration-approved substrate replacement are critical to preserve neurologic function. This article discusses 2 children who presented with late-onset molybdenum cofactor deficiency type A.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Developmental Disabilities / Metal Metabolism, Inborn Errors Limits: Humans Language: En Journal: Pediatrics Year: 2024 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Developmental Disabilities / Metal Metabolism, Inborn Errors Limits: Humans Language: En Journal: Pediatrics Year: 2024 Document type: Article